title: Correlation between advanced glycation end-products and the expression of fatty inflammatory factors in type II diabetic cardiomyopathy.
abstract: Diabetic cardiomyopathy (DCM) is one of the most severe complications of diabetes without a clear pathogenesis. Th is study investigated the adiponectin (APN) and leptin levels in type II DCM, as well as their correlation with advanced glycation end-products (AGEs). From 2011-2013, 78 type II diabetes mellitus (T2DM) cases (40-65 years old) in the Taian region were randomly selected. Based on the results of colour Doppler ultrasonography and coronary angiography, the cases were divided into a simple T2DM group (40 cases) and a DCM group (38 cases). Forty healthy subjects were used as normal control (NC). An enzyme-linked immunosorbent assay was performed to determine the levels of fa tty inflammatory factors such as APN, leptin and AGEs, and a correlation analysis was conducted. In the T2DM group, the APN levels were decreased but the leptin and AGE levels were significantly increased compared to the NC group. In the DCM group, the APN levels were decreased but the leptin and AGE levels were significantly increased (P<0.01) compared to the T2DM group. Th e AGE levels were positively correlated with disease progression and with fasting plasma glucose levels, glycated haemoglobin, insulin resistance and leptin, but were negatively correlated with APN levels. Additionally, the APN and leptin levels were independently related to the AGE levels. Fatty inflammatory factors play a significant role in the progression of both simple T2DM and DCM. Th e results of this study revealed the pathogenesis of DCM and indicated the potential significance of AGEs in DCM prevention and treatment.
authors.affiliation: Affiliated Hospital of Taishan Medical University, Tai'an 271000, China. gyozhengcn@163.com.
authors.forename: Zhengdong
authors.initials: Z
authors.lastname: Guo
authors.forename: Donghui
authors.initials: D
authors.lastname: Huang
authors.forename: Xiange
authors.initials: X
authors.lastname: Tang
authors.forename: Jingjing
authors.initials: J
authors.lastname: Han
authors.forename: Jing
authors.initials: J
authors.lastname: Li
mesh_terms: D052242:Adiponectin / Q000096:biosynthesis* / Q000235:genetics; D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000378:metabolism*; D058065:Diabetic Cardiomyopathies / Q000378:metabolism*; D018450:Disease Progression; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D017127:Glycation End Products, Advanced / Q000378:metabolism*; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism*; D007333:Insulin Resistance; D020738:Leptin / Q000096:biosynthesis* / Q000235:genetics; D008297:Male; D008875:Middle Aged
chemical_list: D052242:Adiponectin; D001786:Blood Glucose; D006442:Glycated Hemoglobin; D017127:Glycation End Products, Advanced; D018836:Inflammation Mediators; D020738:Leptin; C499918:ADIPOQ protein, human